NO20001728L - FremgangsmÕte for fremstilling av chirale forbindelser - Google Patents
FremgangsmÕte for fremstilling av chirale forbindelserInfo
- Publication number
- NO20001728L NO20001728L NO20001728A NO20001728A NO20001728L NO 20001728 L NO20001728 L NO 20001728L NO 20001728 A NO20001728 A NO 20001728A NO 20001728 A NO20001728 A NO 20001728A NO 20001728 L NO20001728 L NO 20001728L
- Authority
- NO
- Norway
- Prior art keywords
- methyl
- phenylpropylamine
- hydroxy
- formula
- compound
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims description 20
- 238000000034 method Methods 0.000 title claims description 20
- 238000002360 preparation method Methods 0.000 title claims description 7
- XXSDCGNHLFVSET-SNVBAGLBSA-N (1r)-3-(methylamino)-1-phenylpropan-1-ol Chemical compound CNCC[C@@H](O)C1=CC=CC=C1 XXSDCGNHLFVSET-SNVBAGLBSA-N 0.000 claims description 22
- IWYDHOAUDWTVEP-ZETCQYMHSA-N (S)-mandelic acid Chemical class OC(=O)[C@@H](O)C1=CC=CC=C1 IWYDHOAUDWTVEP-ZETCQYMHSA-N 0.000 claims description 10
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 claims description 10
- 150000004703 alkoxides Chemical class 0.000 claims description 8
- 229960002464 fluoxetine Drugs 0.000 claims description 8
- IWYDHOAUDWTVEP-SSDOTTSWSA-N (R)-mandelic acid Chemical class OC(=O)[C@H](O)C1=CC=CC=C1 IWYDHOAUDWTVEP-SSDOTTSWSA-N 0.000 claims description 7
- XXSDCGNHLFVSET-UHFFFAOYSA-N 3-(methylamino)-1-phenylpropan-1-ol Chemical compound CNCCC(O)C1=CC=CC=C1 XXSDCGNHLFVSET-UHFFFAOYSA-N 0.000 claims description 6
- -1 N-methyl-3R-(substituted phenoxy)-3-phenylpropylamines Chemical class 0.000 claims description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 48
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical group CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 41
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 23
- 239000000203 mixture Substances 0.000 description 20
- 235000019439 ethyl acetate Nutrition 0.000 description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 16
- 239000010410 layer Substances 0.000 description 14
- 239000013078 crystal Substances 0.000 description 13
- 238000006243 chemical reaction Methods 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 9
- 238000003786 synthesis reaction Methods 0.000 description 9
- VHGCDTVCOLNTBX-QGZVFWFLSA-N atomoxetine Chemical compound O([C@H](CCNC)C=1C=CC=CC=1)C1=CC=CC=C1C VHGCDTVCOLNTBX-QGZVFWFLSA-N 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- VZIYNJNIJMZLNZ-UNTBIKODSA-N (3R)-N-methyl-3-(2-methylphenyl)sulfanyl-3-phenylpropan-1-amine hydrochloride Chemical compound CC1=CC=CC=C1S[C@H](CCNC)C2=CC=CC=C2.Cl VZIYNJNIJMZLNZ-UNTBIKODSA-N 0.000 description 5
- IUTPYKBKYDVRDB-QGZVFWFLSA-N (3r)-n-methyl-3-(2-methylphenyl)sulfanyl-3-phenylpropan-1-amine Chemical compound S([C@H](CCNC)C=1C=CC=CC=1)C1=CC=CC=C1C IUTPYKBKYDVRDB-QGZVFWFLSA-N 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- 229910000104 sodium hydride Inorganic materials 0.000 description 5
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 4
- 238000005160 1H NMR spectroscopy Methods 0.000 description 4
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 229960002510 mandelic acid Drugs 0.000 description 4
- 239000012044 organic layer Substances 0.000 description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000012312 sodium hydride Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- RTHCYVBBDHJXIQ-MRXNPFEDSA-N (R)-fluoxetine Chemical compound O([C@H](CCNC)C=1C=CC=CC=1)C1=CC=C(C(F)(F)F)C=C1 RTHCYVBBDHJXIQ-MRXNPFEDSA-N 0.000 description 2
- AYTSELVZWGHUEE-UHFFFAOYSA-N 1-fluoro-2-methylsulfanylbenzene Chemical compound CSC1=CC=CC=C1F AYTSELVZWGHUEE-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 229960002430 atomoxetine Drugs 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 229940127557 pharmaceutical product Drugs 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- MMZYCBHLNZVROM-UHFFFAOYSA-N 1-fluoro-2-methylbenzene Chemical compound CC1=CC=CC=C1F MMZYCBHLNZVROM-UHFFFAOYSA-N 0.000 description 1
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- JTXMVXSTHSMVQF-UHFFFAOYSA-N 2-acetyloxyethyl acetate Chemical compound CC(=O)OCCOC(C)=O JTXMVXSTHSMVQF-UHFFFAOYSA-N 0.000 description 1
- QMBFHVFCUYOQJH-UHFFFAOYSA-N 5-fluoro-5-methylsulfanylcyclohexa-1,3-diene Chemical compound FC1(CC=CC=C1)SC QMBFHVFCUYOQJH-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-OUBTZVSYSA-N Carbon-13 Chemical compound [13C] OKTJSMMVPCPJKN-OUBTZVSYSA-N 0.000 description 1
- 239000007832 Na2SO4 Substances 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000012455 biphasic mixture Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000003810 ethyl acetate extraction Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 230000012154 norepinephrine uptake Effects 0.000 description 1
- 239000004533 oil dispersion Substances 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- QULYNCCPRWKEMF-UHFFFAOYSA-N parachlorobenzotrifluoride Chemical compound FC(F)(F)C1=CC=C(Cl)C=C1 QULYNCCPRWKEMF-UHFFFAOYSA-N 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 229940103091 potassium benzoate Drugs 0.000 description 1
- 235000010235 potassium benzoate Nutrition 0.000 description 1
- 239000004300 potassium benzoate Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C211/39—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
- C07C211/40—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing only non-condensed rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/06—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton from hydroxy amines by reactions involving the etherification or esterification of hydroxy groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
- C07C215/28—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
- C07C215/30—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings containing hydroxy groups and carbon atoms of six-membered aromatic rings bound to the same carbon atom of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
- C07C319/20—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by reactions not involving the formation of sulfide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6179897P | 1997-10-14 | 1997-10-14 | |
| PCT/US1998/019874 WO1999018947A1 (en) | 1997-10-14 | 1998-09-23 | Process to make chiral compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20001728D0 NO20001728D0 (no) | 2000-04-04 |
| NO20001728L true NO20001728L (no) | 2000-04-04 |
Family
ID=22038219
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20001728A NO20001728L (no) | 1997-10-14 | 2000-04-04 | FremgangsmÕte for fremstilling av chirale forbindelser |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0909754A1 (xx) |
| JP (1) | JP2001519385A (xx) |
| KR (1) | KR20010015746A (xx) |
| CN (1) | CN1275077A (xx) |
| AR (1) | AR016144A1 (xx) |
| AU (1) | AU744895B2 (xx) |
| BR (1) | BR9813036A (xx) |
| CA (1) | CA2306768A1 (xx) |
| CO (1) | CO4990928A1 (xx) |
| EA (1) | EA200000417A1 (xx) |
| HU (1) | HUP0003807A2 (xx) |
| ID (1) | ID24567A (xx) |
| IL (1) | IL135514A0 (xx) |
| NO (1) | NO20001728L (xx) |
| PE (1) | PE120599A1 (xx) |
| PL (1) | PL339865A1 (xx) |
| TR (1) | TR200000969T2 (xx) |
| TW (1) | TW514634B (xx) |
| WO (1) | WO1999018947A1 (xx) |
| ZA (1) | ZA988635B (xx) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2249256T3 (es) | 1999-04-09 | 2006-04-01 | Eli Lilly And Company | Procedimientos de preparacion de 3-ariloxi-3-arilpropilamidas y sus intermedios. |
| WO2002070457A1 (en) | 2001-03-06 | 2002-09-12 | Eli Lilly And Company | Inhibitor of monoamine uptake |
| SE0100902D0 (sv) | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | Compounds |
| SE0202539D0 (sv) | 2002-08-27 | 2002-08-27 | Astrazeneca Ab | Compounds |
| CN1314658C (zh) * | 2002-09-05 | 2007-05-09 | 武汉大学 | 光学纯n－甲基－3－苯基－3－羟基丙胺的制备方法 |
| DK1720852T3 (da) * | 2004-02-19 | 2012-10-22 | Lonza Ag | Fremgangsmåde til fremstilling af enantiomerrene 1-substituerede 3-aminoalkoholer |
| US7648992B2 (en) | 2004-07-05 | 2010-01-19 | Astrazeneca Ab | Hydantoin derivatives for the treatment of obstructive airway diseases |
| SE0401762D0 (sv) | 2004-07-05 | 2004-07-05 | Astrazeneca Ab | Novel compounds |
| SE0403086D0 (sv) | 2004-12-17 | 2004-12-17 | Astrazeneca Ab | Compounds |
| SE0403085D0 (sv) | 2004-12-17 | 2004-12-17 | Astrazeneca Ab | Novel componds |
| CN100372926C (zh) * | 2005-06-23 | 2008-03-05 | 华东理工大学 | 恶臭假单胞菌及其在拆分扁桃酸外消旋体中的应用 |
| TW200800954A (en) * | 2006-03-16 | 2008-01-01 | Astrazeneca Ab | Novel crystal modifications |
| TW200831488A (en) | 2006-11-29 | 2008-08-01 | Astrazeneca Ab | Novel compounds |
| CN101538542B (zh) * | 2009-04-22 | 2010-12-29 | 华东理工大学 | 一种假单胞菌酯酶及其用于制备光学纯扁桃酸及其衍生物的用途 |
| CN102718669B (zh) * | 2012-06-29 | 2013-12-11 | 海南美大制药有限公司 | 盐酸氟西汀化合物及其新制法 |
| CN102863344B (zh) * | 2012-07-20 | 2015-06-03 | 葫芦岛国帝药业有限责任公司 | 一种托莫西汀药物制备方法 |
| CN105001102B (zh) * | 2015-07-29 | 2017-03-15 | 郑州大学 | 手性拆分制备单一构型氟西汀的方法 |
| CN110294680A (zh) * | 2018-03-22 | 2019-10-01 | 北京深蓝海生物医药科技有限公司 | 一种盐酸阿托莫西汀的制备方法 |
| KR20240030605A (ko) * | 2022-08-31 | 2024-03-07 | 이화여자대학교 산학협력단 | 키랄 금속 산화물 나노 구조체 및 이의 제조 방법 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2060618A (en) * | 1979-09-14 | 1981-05-07 | Wyeth John & Brother Ltd | 3-Aryl-3-Aryloxypropylamines |
| US5166437A (en) * | 1989-03-03 | 1992-11-24 | Orion-Yhtyma Oy | Process for the preparation of fluoxetine |
| FI81083C (fi) * | 1989-03-03 | 1990-09-10 | Orion Yhtymae Oy | Ett foerbaettrat foerfarande foer framstaellning av n-metyl-3-(p-trifluormetylfenoxi)-3-fenylpropylamin hydroklorid. |
| CA2042346A1 (en) * | 1990-05-17 | 1991-11-18 | Michael Alexander Staszak | Chiral synthesis of 1-aryl-3-aminopropan-1-ols |
| US5104899A (en) * | 1990-08-13 | 1992-04-14 | Sepracor, Inc. | Methods and compositions for treating depression using optically pure fluoxetine |
| US5589511A (en) * | 1990-08-13 | 1996-12-31 | Sepracor Inc. | Method for treating migraine headaches using optically pure S(+) fluoxetine |
| HU9202128D0 (en) * | 1992-06-26 | 1992-10-28 | Richter Gedeon Vegyeszet | Method for producing n-methyl-(3-phenyl-3-(4-[trifluoro-methyl])-phenooxi-)-amine |
| WO1995002574A1 (en) * | 1993-07-14 | 1995-01-26 | Smithkline Beecham Corporation | Synthesis of acid addition salts of hydroxylamines |
| JPH0940621A (ja) * | 1995-07-28 | 1997-02-10 | Zeria Pharmaceut Co Ltd | 光学活性インダニルメチルアミン誘導体及びその製造法 |
-
1998
- 1998-09-18 TW TW087115597A patent/TW514634B/zh active
- 1998-09-21 ZA ZA9808635A patent/ZA988635B/xx unknown
- 1998-09-23 CA CA002306768A patent/CA2306768A1/en not_active Abandoned
- 1998-09-23 ID IDW20000682A patent/ID24567A/id unknown
- 1998-09-23 IL IL13551498A patent/IL135514A0/xx unknown
- 1998-09-23 AU AU96636/98A patent/AU744895B2/en not_active Ceased
- 1998-09-23 TR TR2000/00969T patent/TR200000969T2/xx unknown
- 1998-09-23 EA EA200000417A patent/EA200000417A1/ru unknown
- 1998-09-23 WO PCT/US1998/019874 patent/WO1999018947A1/en not_active Application Discontinuation
- 1998-09-23 CN CN98810043A patent/CN1275077A/zh active Pending
- 1998-09-23 JP JP2000515582A patent/JP2001519385A/ja not_active Ceased
- 1998-09-23 KR KR1020007003924A patent/KR20010015746A/ko not_active Application Discontinuation
- 1998-09-23 HU HU0003807A patent/HUP0003807A2/hu unknown
- 1998-09-23 BR BR9813036-6A patent/BR9813036A/pt not_active IP Right Cessation
- 1998-09-23 PL PL98339865A patent/PL339865A1/xx unknown
- 1998-10-09 CO CO98059011A patent/CO4990928A1/es unknown
- 1998-10-09 AR ARP980105045A patent/AR016144A1/es unknown
- 1998-10-13 EP EP98308348A patent/EP0909754A1/en not_active Withdrawn
- 1998-10-13 PE PE1998000969A patent/PE120599A1/es not_active Application Discontinuation
-
2000
- 2000-04-04 NO NO20001728A patent/NO20001728L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999018947A1 (en) | 1999-04-22 |
| HUP0003807A2 (hu) | 2001-04-28 |
| PE120599A1 (es) | 1999-12-02 |
| NO20001728D0 (no) | 2000-04-04 |
| CA2306768A1 (en) | 1999-04-22 |
| AU744895B2 (en) | 2002-03-07 |
| PL339865A1 (en) | 2001-01-15 |
| AR016144A1 (es) | 2001-06-20 |
| IL135514A0 (en) | 2001-05-20 |
| BR9813036A (pt) | 2000-08-15 |
| TR200000969T2 (tr) | 2000-09-21 |
| ID24567A (id) | 2000-07-27 |
| EA200000417A1 (ru) | 2000-10-30 |
| JP2001519385A (ja) | 2001-10-23 |
| ZA988635B (en) | 2000-05-02 |
| CO4990928A1 (es) | 2000-12-26 |
| EP0909754A1 (en) | 1999-04-21 |
| AU9663698A (en) | 1999-05-03 |
| CN1275077A (zh) | 2000-11-29 |
| KR20010015746A (ko) | 2001-02-26 |
| TW514634B (en) | 2002-12-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20001728L (no) | FremgangsmÕte for fremstilling av chirale forbindelser | |
| US11518741B2 (en) | Brivaracetam intermediate, preparation method therefor, and preparation method for brivaracetam | |
| US20040002615A1 (en) | Preparation of chiral amino-nitriles | |
| EP0441160B1 (en) | Process for preparing levo and dextro fenfluramine | |
| JP2012519677A (ja) | シナカルセト及びその塩の製造方法、並びに該方法に使用する中間体 | |
| US7439399B2 (en) | Processes for the preparation of atomoxetine hydrochloride | |
| EP2349976B1 (en) | A process for producing (s)-3-[(1-dimethylamino)ethyl]phenyl-n-ethyl-n-methyl-carbamate via novel intermediates | |
| US6008412A (en) | Process to make chiral compounds | |
| KR101379383B1 (ko) | 고순도 ⒮―메토프롤롤의 제조방법 | |
| MXPA00003560A (en) | Process to make chiral compounds | |
| CZ20001344A3 (cs) | Způsob výroby chirálních sloučenin | |
| EP2739610B1 (en) | Process for the manufacture of ivabradine and of intermediates of synthesis thereof | |
| WO2002068391A1 (en) | Process for resolving racemic mixtures of piperidine derivatives | |
| CN110294680A (zh) | 一种盐酸阿托莫西汀的制备方法 | |
| KR101085170B1 (ko) | (ｓ)-리바스티그민의 제조방법 | |
| WO2009063170A1 (en) | Preparation of crystalline rotigotine base | |
| WO2008037503A2 (en) | Process for making aminoalkylphenyl carbamates and intermediates therefor | |
| EP2938595B1 (fr) | Procede de synthese d'une hydrazine utile dans le traitement du virus du papillome | |
| ES2537378T3 (es) | Un proceso para preparar Fesoterodina | |
| CN116239476A (zh) | 一种盐酸司来吉兰异构体的制备方法 | |
| CA2073833A1 (en) | Substituted 1-phenyl-1-benzoylamino-5-aminopentanes, their preparation and use | |
| JPH0440355B2 (xx) | ||
| CS272528B1 (cs) | Způsob přípravy opticky aktivních fluorsubstituovaných 2,2-dimethylcyklopropankarboxylových kyselin a jejich solí | |
| EP2331492A1 (fr) | Procede de preparation de l'ester ethylique de l'acide 4- [trans-4-[(phenylmethyl)-amino]cyclohexyl]benzoïque et de son sel hemifumarate | |
| WO2014012832A1 (en) | Process for the preparation of 2-(3-n,n-diisopropylamino-1-phenylpropyl)-4-hydroxymethyl-phenol and its derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |